Avoro Capital Advisors’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Avoro Capital Advisors’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-233,333	Closed	-$12K	–	67
2018 Q1	$12K	Hold	233,333	–	–	﹤0.01%	55
2017 Q4	$5K	Hold	233,333	–	–	﹤0.01%	50
2017 Q3	$12K	Hold	233,333	–	–	﹤0.01%	43
2017 Q2	$22K	Hold	233,333	–	–	﹤0.01%	46
2017 Q1	$117K	Hold	233,333	–	–	0.01%	45
2016 Q4	$184K	Hold	233,333	–	–	0.04%	40
2016 Q3	$233K	Hold	233,333	–	–	0.04%	45
2016 Q2	$105K	Buy	+233,333	New	+$123K	0.02%	40

Avoro Capital Advisors's ONSIZ Position: Q2 2018 in Review

Avoro Capital Advisors sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2018, closing a stake of 233,333 shares — an estimated $12K sold.

Avoro Capital Advisors first reported a position in ONSIZ in Q2 2016 and held it in 8 quarters. The position peaked at $233K in Q3 2016. 0 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2018.

Avoro Capital Advisors reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q2 2018 after selling out during the quarter.
Avoro Capital Advisors sold 233,333 Oncobiologics, Inc. Series B Warrant shares in Q2 2018, an estimated $12K.
Avoro Capital Advisors first reported a position in Oncobiologics, Inc. Series B Warrant in Q2 2016 and held it in 8 quarters.
Avoro Capital Advisors's Oncobiologics, Inc. Series B Warrant position peaked at $233K in Q3 2016.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2018.

Based on Avoro Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.